Clinical trial
Prevention of Seasonal Affective Disorder
NCT00046449 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00046449 |
|---|---|
| Title | Prevention of Seasonal Affective Disorder |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seasonal Affective Disorder (SAD) |
| Intervention type | Drug |
| Interventions | Investigational Seasonal Affective Disorder (SAD) Drug |
| Start date | Sep 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Oct 2, 2002 |
| Last update posted | Jun 4, 2015 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: